BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38301645)

  • 1. PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome.
    Xu J; Erlendsson S; Singh M; Holling GA; Regier M; Ibiricu I; Einstein J; Hantak MP; Day GS; Piquet AL; Smith TL; Clardy SL; Whiteley AM; Feschotte C; Briggs JAG; Shepherd JD
    Cell; 2024 Feb; 187(4):831-845.e19. PubMed ID: 38301645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PNMA2 forms non-enveloped virus-like capsids that trigger paraneoplastic neurological syndrome.
    Xu J; Erlendsson S; Singh M; Regier M; Ibiricu I; Day GS; Piquet AL; Clardy SL; Feschotte C; Briggs JAG; Shepherd JD
    bioRxiv; 2023 Feb; ():. PubMed ID: 36798413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human paraneoplastic antigen Ma2 (PNMA2) forms icosahedral capsids that can be engineered for mRNA delivery.
    Madigan V; Zhang Y; Raghavan R; Wilkinson ME; Faure G; Puccio E; Segel M; Lash B; Macrae RK; Zhang F
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307812120. PubMed ID: 38437549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PNMA2 mediates heterodimeric interactions and antagonizes chemo-sensitizing activities mediated by members of PNMA family.
    Lee YH; Pang SW; Tan KO
    Biochem Biophys Res Commun; 2016 Apr; 473(1):224-229. PubMed ID: 27003254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
    Hoffmann LA; Jarius S; Pellkofer HL; Schueller M; Krumbholz M; Koenig F; Johannis W; la Fougere C; Newman T; Vincent A; Voltz R
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):767-73. PubMed ID: 18223018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesothelioma and anti-Ma paraneoplastic syndrome; heterogeneity in immunogenic tumours increases.
    Archer HA; Panopoulou A; Bhatt N; Edey AJ; Giffin NJ
    Pract Neurol; 2014 Feb; 14(1):33-5. PubMed ID: 23749880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune channelopathies in paraneoplastic neurological syndromes.
    Joubert B; Honnorat J
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune Retinopathy Caused by Anti-Paraneoplastic Antigen MA2: A Case Study.
    Fukushima A; Tabuchi H
    Case Rep Ophthalmol; 2022; 13(2):419-423. PubMed ID: 35811772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
    Yamamoto T; Tsuji S
    Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNMA family: Protein interaction network and cell signalling pathways implicated in cancer and apoptosis.
    Pang SW; Lahiri C; Poh CL; Tan KO
    Cell Signal; 2018 May; 45():54-62. PubMed ID: 29378289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against glial antigens in paraneoplastic neurological diseases.
    Tschernatsch M; Gross O; Kneifel N; Krasenbrink I; Gerriets T; Kaps M; Blaes F
    Ann N Y Acad Sci; 2007 Jun; 1107():104-10. PubMed ID: 17804537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model.
    Yshii LM; Gebauer CM; Pignolet B; Mauré E; Quériault C; Pierau M; Saito H; Suzuki N; Brunner-Weinzierl M; Bauer J; Liblau R
    Brain; 2016 Nov; 139(11):2923-2934. PubMed ID: 27604307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paraneoplastic neurological syndrome associated with anti-Ma2 antibodies].
    Khammassi N; Balhouane I; Gargouri A; Gouider R; Cherif O
    Rev Neurol (Paris); 2012 Feb; 168(2):192-3. PubMed ID: 21962240
    [No Abstract]   [Full Text] [Related]  

  • 14. Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.
    Vogrig A; Joubert B; Maureille A; Thomas L; Bernard E; Streichenberger N; Cotton F; Ducray F; Honnorat J
    J Neurol; 2019 Feb; 266(2):398-410. PubMed ID: 30498914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.
    Cui T; Hurtig M; Elgue G; Li SC; Veronesi G; Essaghir A; Demoulin JB; Pelosi G; Alimohammadi M; Öberg K; Giandomenico V
    PLoS One; 2010 Dec; 5(12):e16010. PubMed ID: 21209860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes.
    Ortega Suero G; Sola-Valls N; Escudero D; Saiz A; Graus F
    Neurologia (Engl Ed); 2018; 33(1):18-27. PubMed ID: 27460184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paraneoplastic neurological syndromes: an update].
    Zekeridou A; Ferfoglia RI; Du Pasquier R; Lalive PH
    Rev Med Suisse; 2016 Apr; 12(516):832-4, 836-9. PubMed ID: 27281941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ma2-associated paraneoplastic encephalitis in a male adolescent with mediastinal seminoma.
    Bosemani T; Huisman TA; Poretti A
    Pediatr Neurol; 2014 Apr; 50(4):433-4. PubMed ID: 24630289
    [No Abstract]   [Full Text] [Related]  

  • 19. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
    Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
    Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.